fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and.
when his patients ask how long they’ll be at the hospital with a procedure like this, he tries to manage their expectations..
"the treatment of our family and the behaviour of the western trust has been disgraceful, they should be ashamed of themselves...treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic).